Navigation Links
ICON Selected to Manage Lilly Clinical Trial Site Set Up and Monitoring in Europe
Date:6/9/2009

DUBLIN, June 9 /PRNewswire-FirstCall/ -- ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has signed a strategic partnership with Eli Lilly and Company (NYSE: LLY) to manage the company's clinical trial site set up and monitoring in Europe for Lilly managed studies. The agreement, which is subject to the relevant employee consultation processes, is a continuation of Lilly's ongoing transformation of its research and development organisation and follows Lilly's selection of ICON to manage its clinical data management business outside of the US, which was announced in November 2008.

"Today's announcement marks another milestone in the successful partnership between ICON and Lilly," commented Peter Gray, CEO at ICON. "We have worked together to create a truly flexible model that better meets Lilly's patient and portfolio needs and will also drive productivity within Lilly's clinical operations in Europe. We look forward to continuing to assist Lilly with its transformation initiatives and to delivering the quality services that will expedite their drug development pipelines."

"We are constantly evaluating how we can do things better to increase our flexibility and focus our internal efforts on our core capabilities," commented Jeff Kasher, Lilly Vice President and Chief Operating Officer of Global Clinical Development." This strategic agreement enables us to leverage ICON's significant expertise in clinical trial monitoring and site management in Europe and will increase our ability to speed innovative medicines to patients."

About ICON plc

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has over 7,100 employees, operating from 71 locations in 38 countries.

Further information is available at http://www.iconplc.com

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs.

    ICON/ICLR-G

    US contact:
    Courtney Judd
    +1-212-445-8365
    cjudd@webershandwick.com

    UK contact:
    Erika Aalto
    +44(0)20-706-70-214
    eaalto@webershandwick.com



'/>"/>
SOURCE ICON plc
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Brooke Franchise Corporation Announces Selected July Results
2. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
3. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
4. Crdentia Selected by High Rock Raceway to Provide Healthcare Staffing Services
5. Fry Construction Selected for High-Profile Medical Imaging Project
6. Meth Project Advertisements Selected for National Prevention Campaign
7. Eight Graduate Nursing Students Selected to Receive The California Endowment-AACN Minority Nurse Faculty Scholarship
8. CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits
9. SAIC Selected to Support the U.S. Military Theater Medical Information Program-Joint
10. The Cooper Institutes FITNESSGRAM Selected as Statewide Physical Fitness Assessment Tool
11. CBaySystems Selected to Receive Deloittes 2007 Maryland Technology Fast 50 Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2018)... ... December 05, 2018 , ... Advanced Clinical, a clinical ... new office location in Paris, France during the Partnerships in Clinical Trials Europe ... Europe and additional in-country personnel. , “The new office broadens our CRO and ...
(Date:12/5/2018)... ... December 05, 2018 , ... Dr. Jessica Allen of Northern Colorado Periodontics is ... ailing dental implants in the Fort Collins area. Dr. Allen joins an elite class ... bone and tissues lost to gum disease. , "Gum disease is a problem that ...
(Date:12/5/2018)... (PRWEB) , ... December 05, 2018 , ... ... philosophy reinforces the theme of Unitek’s transformative conference at the DoubleTree Hilton Hotel ... FAAN, LL (AAN), Distinguished Professor and Founder/Director of Watson Caring Science Institute, participants ...
(Date:11/29/2018)... , ... November 29, 2018 ... ... published and released last month in the journal BMC Infectious Diseases published ... bins are crawling with infectious viruses that can cause serious and in ...
(Date:11/28/2018)... ... 28, 2018 , ... Melania Trump, first lady of the United States, took ... event addressing the national opioid epidemic. The event was filmed for the pilot episode ... to an accidental opioid overdose last year. The program is scheduled to air nationally ...
Breaking Medicine News(10 mins):
(Date:12/5/2018)... ... December 05, 2018 , ... NDA Partners Chairman ... Director of Global Laboratory Integration at the United States Pharmacopeial Convention (USP), has ... executive with extensive experience in domestic and international operations harmonization, compendial affairs, and ...
(Date:11/29/2018)... ... November 29, 2018 , ... Designs for ... the launch of the Annatto-E™ product line, containing unique and natural vitamin E ... research, DFH’s new Annatto-E™ products are available in three dosages of 75mg (with ...
(Date:11/29/2018)... ... November 29, 2018 , ... Windsor Gardens Healthcare Center of the Valley (“Windsor ... announced today they were selected by the California Association of Health Facilities (CAHF) as ... Project. , The California Department of Public Health awarded a grant of $700,000 ...
Breaking Medicine Technology: